TrkA overexpression enhances growth and metastasis of breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TrkA overexpression enhances growth and metastasis of breast cancer cells

Published:2009-03-30 Issue:18 Volume:28 Page:1960-1970
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Lagadec C,Meignan S,Adriaenssens E,Foveau B,Vanhecke E,Romon R,Toillon R -A,Oxombre B,Hondermarck H,Le Bourhis X

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc200961.pdf

Reference31 articles.

1. Adriaenssens E, Vanhecke E, Saule P, Mougel A, Page A, Romon R et al. (2008). Nerve growth factor is a potential molecular target in breast cancer. Cancer Res 68: 346–351.

2. Aragona M, Panetta S, Silipigni AM, Romeo DL, Pastura G, Mesiti M et al. (2001). Nerve growth factor receptor immunoreactivity in breast cancer patients. Cancer Invest 19: 692–697.

3. Campos X, Munoz Y, Selman A, Yazigi R, Moyano L, Weinstein-Oppenheimer C et al. (2007). Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer. Gynecol Oncol 104: 168–175.

4. Cantarella G, Lempereur L, Presta M, Ribatti D, Lombardo G, Lazarovici P et al. (2002). Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 16: 1307–1309.

5. Chao MV . (1994). The p75 neurotrophin receptor. J Neurobiol 25: 1373–1385.

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the peripheral neural-tumour microenvironment for cancer therapy;Nature Reviews Drug Discovery;2024-09-06

2. Design, Synthesis, and Biological and in silico Evaluation of Novel Indazole-pyridine Hybrids for the Treatment of Breast Cancer;Current Computer-Aided Drug Design;2024-08-06

3. Targeting anoikis resistance as a strategy for cancer therapy;Drug Resistance Updates;2024-07

4. NTRK-rearranged spindle cell neoplasm: Initial observation of imaging appearance and clinicopathologic correlation;Clinical Imaging;2024-06

5. Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update;Expert Opinion on Therapeutic Patents;2024-04-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3